https://www.selleckchem.com/products/ptc596.html
Belatacept conversion is a good and safe option in patients with deteriorating renal function attributed to CNI nephrotoxicity. A better understanding of the mechanisms underlying calcineurin inhibitor nephrotoxicity could help in the individualization of therapy for and prevention of CNI nephrotoxicity. Identification of high-risk patients for CNI nephrotoxicity before renal transplantation enables better use and selection of immunosuppression with reduced adverse effects and, eventually, successful treatment of the kidney recipients. B
Like
Comment
Share
